Addressing Health Disparities in African Americans - Exploring Sleep and Developing Interventions

Sleep Clinical Trial

— HD-SLEEP1  

Official title:

Addressing Health Disparities in African Americans - Exploring Sleep and Developing Interventions

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05102175
• Other study ID #: PBRC 2020-020-1
• Secondary ID: U54GM104940
• Status: Completed
• Start date: November 1, 2021
• Est. completion date: August 24, 2022

Study information

• Verified date: August 2022
• Source: Pennington Biomedical Research Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of the HD-SLEEP1 study is to help researchers understand what African Americans know and think about sleep. The investigators also want to know how to encourage people to participate in research studies designed to improve sleep.

Description:

African Americans (AAs) sleep worse than whites on average, thus contributing to race disparities in major health outcomes. However, contributors to poorer sleep and effective interventions to improve sleep among AAs is lacking due to under-representation of AAs in sleep research. The investigators propose to address this knowledge gap through engagement with the Baton Rouge African American community. The investigators will use focus groups to determine sleep-related perceptions as well as barriers to sleep research recruitment and retention.

In this study, up to 60 African Americans who self-report poor sleep will be invited to participate in focus group discussions to understand 1) sleep related perceptions; 2) factors influencing participation; and 3) willingness to undertake study procedures typical of sleep research studies such as increasing sleep duration, diagnosing and treating OSA; along with other routine research procedures including blood draws, caloric restriction, and body composition exams.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 36
• Est. completion date: August 24, 2022
• Est. primary completion date: August 24, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Self-identified African American

• Age range: >18 years (inclusive)

• Sex: Both males and females will be allowed to participate in the study

• Self-perceived poor sleep

• Willing to be audio and video recorded

Exclusion Criteria:

• Unable to provide written informed consent

• Unable to understand English

Related Conditions & MeSH terms

• Sleep

Intervention

Other:
• Focus Group
Eligible participants will be invited to a semi-structured focus group discussion. Each group will include 8 -12 participants.

Locations

Country	Name	City	State
United States	Recruiting core Pennington	Baton Rouge	Louisiana

Sponsors (2)

Lead Sponsor	Collaborator
Pennington Biomedical Research Center	National Institute of General Medical Sciences (NIGMS)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Importance of Sleep	Identify if sleep is considered important for health	1 day
Primary	Knowledge related to components of good sleep	Identify adequate sleep duration, good sleep quality, and absence of sleep disorders as important.	1 day
Primary	Perceived advantages related to participating in sleep-related	May improve health and quality of life	1 day
Primary	Identify what challenges prevents participation in sleep-related research	Willingness to undertake sleep related study procedures and time commitment	1 day
Primary	Identify facilitators to participation in sleep research	At-home assessments, study location, number of study visits	1 day